Skip to main content
European Journal of Radiology Open logoLink to European Journal of Radiology Open
. 2019 Jul 11;6:258–264. doi: 10.1016/j.ejro.2019.07.002

Superior ophthalmic vein thrombosis: What radiologist and clinician must know?

Houman Sotoudeh a,, Omid Shafaat b, Noha Aboueldahab c, Michael Vaphiades d, Ehsan Sotoudeh e, Joshua Bernstock f
PMCID: PMC6796573  PMID: 31641683

Highlights

  • Incidental SOVT: good prognosis, self-limited and treated by anticoagulation.

  • Post-traumatic and surgical SOVT: good prognosis, treated by anticoagulation.

  • Septic SOVT: secondary to infections, high risk, requires specific interventions.

  • Aseptic SOVT: secondary to inflammatory diseases, need to treat underlying etiology.

  • CT and MRI are vital to the correct diagnosis and management of patients with SOVT.

Abbreviations: SOVT, superior ophthalmic vein thrombosis; CST, cavernous sinus thrombosis; CCF, carotid cavernous fistula; CT, computed tomography; MRI, magnetic resonance Imaging; IRB, institutional review board; SOV, superior ophthalmic vein; SCC, Squamous Cell Carcinoma; SLE, systemic lupus erythematosus; RA, rheumatoid arthritis; M, male; F, female; Y, yes; R, right; L, left; N/A, not applicable; B/L, bilateral; UTI, Urinary Tract Infection

Keywords: Superior ophthalmic vein thrombosis, Thrombophlebitis, Cavernous sinus thrombosis, Orbital cellulitis, Sinusitis

Abstract

Purpose

Superior ophthalmic vein thrombosis (SOVT) is an extremely rare condition. Few studies have been published about clinical aspects of this condition. In this study, we have studied the symptoms, underlying etiologies, treatment, pathogenesis and complication of the SOVT and we tried to classify it based on the etiology, treatment, and prognosis.

Methods

We reviewed the patients’ data from a tertiary academic referral center. Each patient with SOVT was then reviewed for symptoms associated with SOVT, underlying etiology, treatment protocol, treatment response, complications, possible pathogens, and final outcome.

Results

Twenty-four cases of SOVT were included in this study. Overall, 13 cases were diagnosed as right-sided SOVT, out of which, eight had simultaneous right-sided cavernous sinus thrombosis (CST). Eighteen cases were diagnosed to have left-sided SOVT, out of which, 11 had simultaneous left-sided CST.

Conclusions

The SOVT can be secondary to different mechanisms. The SOVT secondary to trauma, recent surgery and coagulopathy are mostly non-aggressive, and can be managed by conservative therapy and anticoagulation. The SOVT in patients with orbital cellulitis, history of active sinusitis or paranasal sinus surgery are aggressive presenting with acute orbital swelling, abscess and visual loss. This type of SOVT can be complicated by extension to the cavernous sinus and intracranial structures. These patients require urgent antibiotics therapy and sinus surgery. The most severe type of SOVT is caused by mucormycosis which may also extend intracranially resulting in stroke and is often life-threatening.

1. Introduction

Superior ophthalmic vein thrombosis (SOVT) is extremely rare (incidence of 3–4 cases/million/year) but potentially devastating clinical entity [1,2]. The SOVT can be secondary to septic or aseptic causes. Septic causes include orbital cellulitis, paranasal sinusitis, and septic cavernous sinus thrombosis (CST). Aseptic etiologies are secondary to facial trauma or inflammation, spontaneous carotid cavernous fistula (CCF), hypercoagulable states, orbital neoplasm and Tolosa–Hunt syndrome [[3], [4], [5], [6]]. Orbital infections by aerobic or anaerobic organisms are the most common cause of the SOVT. The most common pathogens causing orbital cellulitis are Staphylococcus aureus and Streptococcus family [4,6]. Clinically, SOVT manifests with painful ptosis and proptosis, conjunctival congestion and chemosis alone with visual loss which and can be detected on post-contrast computed tomography (CT) or magnetic resonance Imaging (MRI) [1,[4], [5], [6]]. The superior ophthalmic vein originates in the superior inner angle of the orbital cavity and takes a course with superior orbital artery to drain into the cavernous sinus. The SOVT can develop into CST, with involvement of the cranial nerves within the cavernous sinus and intracranial complications [7]. Appropriate and rapid treatment based on the underlying etiology is required to prevent the catastrophic consequences and complications of the SOVT [8]. There is no universal treatment protocol for the SOVT due to its rarity. Most of the published studies in this field are case reports or case series with a limited number of patients. To date, 69 cases of the SOVT have been published in the English literature via Medline search. In this study, we represent a cohort of SOVT cases with attention to risk factors, etiology, treatment, complications, prognosis and outcome. In addition we classify the SOVT based on the underlying etiology and suggest the appropriate therapy in each group. In the cases of septic SOVT we review the microbiology and the underlying causative organisms.

2. Materials and methods

This study was approved by our university review board (IRB No 300001833). The electronic data of our institution were reviewed from 2005 to 2018 for cases with diagnosis of the SOVT. All images were reviewed by one neuroradiologist (HS) with 11 years of experience. Patients with enlargement of the SOV containing filling defect on post-contrast images were included in this study (Fig. 1, Fig. 2). The patients with enlargement or varix of the SOV without internal filling defects were excluded. The CST was considered as a filling defect in the expanded cavernous sinus on post-contrast CT or MR (Fig. 3). For each case, all available images were reviewed documenting orbital complications of SOVT, including extension of the thrombosis to the cavernous sinuses and intracranial structures. For each case, the entire electronic file was reviewed. The demographic data, past medical history, underlying comorbidities, presenting symptoms, treatment and responses, complications, final outcome and mortality related to the SOVT were documented (Fig. 4, Fig. 5, Fig. 6, Fig. 7, Fig. 8).

Fig. 1.

Fig. 1

Coronal post-contrast T1 weighted MRI demonstrates dilation of the left superior ophthalmic vein with internal filling defect. Diagnostic for the left SOVT (arrow).

Fig. 2.

Fig. 2

Coronal post-contrast CT demonstrates dilation of the right superior ophthalmic vein with internal thrombosis consistent with right SOVT (arrow).

Fig. 3.

Fig. 3

Coronal post-contrast coronal CT demonstrates expansion of the cavernous sinuses with internal filling defect diagnostic for bilateral cavernous sinus thrombosis (arrows).

Fig. 4.

Fig. 4

Coronal post-contrast T1 sequence shows evidence of bilateral SOVT with expansion of veins and lack of enhancement (arrows).The patient is status post functional sinus surgery with persistent sinusitis.

Fig. 5.

Fig. 5

Coronal post-contrast T1 show left SOVT (arrow A) with thrombosis of bilateral cavernous sinuses (arrow B).

Fig. 6.

Fig. 6

Axial and coronal post-contrast T1 show left sided SOVT (arrows A and B) with extension to left cavernous sinus (arrow C). Evidence of left orbital cellulitis is also noted.

Fig. 7.

Fig. 7

Coronal post-contrast CT shows bilateral SOVT with venous dilation and lack of enhancement (arrows).

Fig. 8.

Fig. 8

Axial and coronal post-contrast CT show right SOVT with dilation and lack of enhancement (arrows A and B).

3. Results

Over a 13-year period, 24 patients with documented SOVT were included; 13 female and 11 male with a mean age of 56.9 years, (SD = 13.2, range 29–85). Thirteen cases of right-sided SOVT were detected, 8 of which had simultaneous right-sided CST. Eighteen cases of left-sided SOVT were noted, 11 of which had simultaneous left-sided CST. Twelve cases were septic, 9 of which were managed surgically. One case of sinus Squamous Cell Carcinoma (SCC) and SOVT was treated by prednisolone and radiotherapy. One case of CCF did not receive any treatment besides regular follow-up. Three cases of incidentally detected SOVT were treated with Aspirin and Warfarin. Four cases of post-traumatic and two cases of post-surgical SOVT were managed conservatively. One case had long-lasting coagulopathy and received anticoagulation. In eleven cases, all belonging to the septic group, complications were noted. In 10 out of 12 cases of septic SOVT, microbiologic culture results were included. Patients’ demographic data, underlying etiologies, past medical histories, symptoms, treatments, complications, pathogens and outcome are presented in Table 1.

Table 1.

Patient’s demographic data, underlying etiologies, past medical histories, symptoms, treatments, complications, microbiology and outcomes. M: Male; F: Female; Y: Yes; R: Right; L: Left; N/A: Not applicable, B/L: Bilateral, SCC: Squamous Cell Carcinoma, CCF: carotid-cavernous fistula, SLE: Systemic lupus erythematosus, RA: Rheumatoid arthritis, SOVT: Superior ophthalmic vein thrombosis, CST: Cavernous sinus thrombosis, UTI: Urinary Tract Infection.

Case Underlying etiology Past medical history Sex Age Symptoms Thrombosis Surgical treatment Medical treatment Complications Pathogen in case of infection
1 Chronic sinusitis (Fig. 4) SLE, RA, hypertension, depression, anxiety, drug abuse F 46 Head ache and R eye swelling, altered mental status B/L SOVT, B/L CST Endoscopic B/L frontal, ethmoidal, maxillary and sphenoidal sinusotomy Dexamethasone, vancomycin, ceftriaxone, metronidazole Subdural empyema and meningitis Methicillin-sensitive Staphylococcus aureus, rare E. coli, few Staph epidermis
2 SCC of L maxillary sinus SCC L maxillary sinus T4bN2MX status post chemo-radiation (cisplatin and taxotere) M 53 L facial swelling, L eye vision loss LSOVT and LCST No Dexamethasone and radiation No N/A
3 Motor vehicle collision Hypertension, diabetes, gastroesophageal reflux and diabetic retinopathy M 53 Head trauma B/L SOVT and B/L CST No Aspirin No N/A
4 R anterior skull base meningioma status post resection Otherwise healthy M 50 No Orbital Symptom RSOVT and RCST No Aspirin No N/A
5 B/L Indirect CCF Status Post Arterial Embolization Anorexia related to nausea F 78 L eye swelling LSOVT and B/L CST No No No N/A
6 B/L orbital cellulitis and meningitis No data F 68 B/L orbital swelling B/LSOVT and B/L CST No data No data R optic nerve infarct and meningitis on imaging No data
7 Motor vehicle collision with L globe tearing status post-surgery and repair complicated by L orbital cellulitis Atrial fibrillation, coronary artery disease, hypothyroidism F 79 L eye swelling LSOVT No Bacitracin, polymyxin B, prednisolone No No culture performed
8 L eye cellulitis Congenital R blindness, history of sinus surgery M 29 Headache, L eye swelling and pain, L sided vision loss LSOVT L orbital decompression, L sinusotomy Vancomycin, piperacillin/ tazobactam, dexamethasone, enoxaparin, coumadin, prednisone Diminished L vision and orbital abscess B-hemolytic Streptococcus
9 Incidentally Noted SOVT on Brain CT done for Altered Mental Status Advanced Dementia, Active Urinary Tract Infection (UTI), Benign prostate Hypertrophy (BPH), Hypothyroidism M 85 No orbital symptom LSOVT No Aspirin, heparin, ceftriaxone (for UTI) No N/A
10 Acute sinusitis with orbital cellulitis Chronic Sinusitis F 70 L eye swelling LSOVT L frontal, ethmoidal, maxillary, and sphenoid sinusotomy. L anterior orbitotomy with drainage of two sub periosteal abscesses Amoxicillin, cephalexin, ciprofloxacin Myositis of L medial and superior rectus muscles and orbital abscess Pseudomonas aeruginosa
11 Head trauma Otherwise healthy M 45 No eye symptom RSOVT No Bacitracin, polymyxin B, and enoxaparin No N/A
12 Incidentally noted SOVT during work up for carotid artery stenosis Carotid stenosis, coronary artery disease status post CABG F 49 No eye symptom RSOVT No Aspirin No N/A
13 L sphenoidal sinusitis, L orbital cellulitis (Fig. 5) Chronic sinusitis, diabetes mellitus F 68 Headache LSOVT and B/L CST Functional endoscopic sinus surgery (FESS) with revision sphenoidectomy Vancomycin, piperacillin-tazobactam, coumadin, Enoxaparin L internal jugular vein thrombosis, B/L abducens nerve palsy coagulase-negative staphylococci
14 R orbital cellulitis Breast cancer F 63 R eye swelling B/L SOVT and B/L CST R orbital abscess drainage, R maxillary and sphenoidal sinusotomy Ceftriaxone, cefepime, vancomycin, metronidazole, amphotericin B L temporal lobe abscess and abscess Staphylococcus aureus
15 L orbital cellulitis (Fig. 6) Chronic sinusitis F 54 L eye swelling LSOVT and LCST Endoscopic B/L pan-sinusotomy amoxicillin/clavulanate, clindamycin, levofloxacin, ceftriaxone, vancomycin, metronidazole, amphotericin B, enoxaparin, heparin, warfarin, dexamethasone Septic thrombophlebitis from transverse sinus to internal jugular vein and skull base osteomyelitis Staphylococcus epidermis, Staphylococcus intermedius
16 Hyper coagulation. Persistently elevated factor VIII Level. Coagulation work-up is otherwise negative Hypertension, asthma, history of deep vein thrombosis 20 years ago F 56 L visual loss LSOVT No Heparin, Enoxaparin, Coumadin N/A
17 Sinusitis and L eye cellulitis History of functional endoscopic sinus surgery (FESS), diabetes mellitus, hypertension M 42 L eye swelling LSOVT and LCST No Clindamycin, Vancomycin, Piperacillin-Tazobactam, Amphotericin B L hemispheric infarction and death Mucormycosis
18 Assault by knife with subdural hematoma Otherwise healthy M 53 Trauma LSOVT L parietal craniotomy. Evacuation of subdural hematoma. Debridement of skull fracture. Ceftriaxone No N/A
19 Incidentally noted SOVT by MRI For migraine Sjogren's syndrome, hypothyroidism F 51 No orbital symptom B/L SOVT No Warfarin No N/A
20 Acute sinusitis Cocaine abuse, cirrhosis, diabetes mellitus M 58 R eye swelling B/L SOVT and B/L CST Drainage of orbital abscess, R frontal, ethmoidal, maxillary and Sphenoidal Sinusotomy Amphotericin B, vancomycin, heparin Sepsis secondary to acute sinusitis Methicillin-Resistant Staphylococcus aureus (MRSA)
21 Maxillofacial fractures status post orbital reconstruction Otherwise healthy F 39 Trauma RSOVT No Enoxaparin No N/A
22 B/L orbital cellulitis (Fig. 7) Allergic fungal sinusitis, chronic headache, hypertension, gout M 52 L eye swelling followed by R eye swelling B/L SOVT and B/L CST B/L maxillary antrostomy, ethmoidal and sphenoidal sinusotomy Vancomycin, amoxicillin-clavulanate B/L cranial Nerve 3rd,4th and 6th paralysis and orbital abscess Staphylococcus epidermidis, Streptococcus viridans. No Fungus Isolated
23 Motor vehicle collision Depression, hypertension F 65 Facial ecchymosis RSOVT No Enoxaparin No N/A
24 Acute R ethmoidal and sphenoidal sinusitis (Fig. 8) Hypertension, chronic sinusitis, prior stoke, narcolepsy, nephrolithiasis and benign prostate hypertrophy M 61 R proptosis, opthalmoplegia and lethargy RSOVT and B/L CST Functional endoscopic sinus surgery, ventriculostomy Cefepime, enoxaparin, dexamethasone, intrathecal tobramycin L 6th nerve palsy, ventriculitis Streptococcus intermedius, Streptococcus constellatus, Staphylococcus epidermidis and Pseudomonas aeruginosa.

4. Discussion

The SOV is the main draining venous structure in orbit. The SOVT is a rare condition with only 69 cases reported to date [9]. The primary clinical presentation of SOVT is acute painful proptosis, chemosis, conjunctival congestion, and visual loss [10].

The SOVT can be secondary to many underlying etiologies including: infectious (paranasal sinusitis, orbital cellulitis and septic cavernous sinus thrombosis with the extension of the thrombus into the SOV) and aseptic (spontaneous or treated thrombosed CCF, neoplastic invasion of the cavernous sinus and orbit, Tolosa–Hunt syndrome and maxillofacial trauma) [[4], [5], [6],11]. Many systemic disorders are associated with the SOVT including hypercoagulable states (thrombocytosis, sickle cell trait, hereditary hemorrhagic telangiectasia, antiphospholipid syndrome, use of oral contraceptive pills, and pregnancy). In this study, we detected a case of SOVT because of hypercoagulability state secondary to long lasting elevated factor VIII. Inflammatory diseases (Graves’ disease, systemic lupus erythematosus, sarcoidosis, Behçet syndrome, amyloidosis, vasculitis and ulcerative colitis) have been reported to be associated with the SOVT [[4], [5], [6],12]. We detected SOVT in a case with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) and a case of Sjogren's syndrome. There are several reported cases of SOVT in SLE with and without antiphospholipid syndrome. The SOVT in SLE without antiphospholipid syndrome is attributed to inflammation and SOVT in SLE with the antiphospholipid syndrome is attributed to hypercoagulation [[13], [14], [15]]. There is an association between the systemic malignancies (leukemia, lymphoma, multiple myeloma, lung cancer and amyloidosis) and the SOVT [[3], [4], [5], [6],16,17]. We also detected a case of breast cancer with SOVT although the patient was complicated by cellulitis.

Regarding the clinical presentation of SOVT, symptoms are secondary to impaired orbital venous drainage including orbital swelling, pain, chemosis, eyelid edema, proptosis, limited ocular motility, with or without fundus findings, and impaired visual acuity [9]. Because of overlap in diagnosis, neuroimaging plays a critical role in the diagnosis of SOVT. The main imaging finding is dilation of the SOV with internal filling defects. Soft tissue stranding around the SOV and within the orbital fat and enlargement of the extraocular muscles are the other imaging findings. Asymmetric dilation of the SOV by itself is not diagnostic for the SOVT. Only about 10% of dilated SOVs are because of the thrombosis [18] which emphasizes the role of contrast imaging.

The SOVT may be unilateral or bilateral and it can be associated with CST. In our study, we had 13 cases of right-sided SOVT and 18 left-sided SOVT. In 13 cases, the cavernous sinus was involved as well. In 6 cases, both SOV and cavernous sinuses were involved.

Among 24 cases, 12 patients had septic SOVT, all of which had evidence of mucosal thickening in paranasal sinuses consistent with either acute or chronic sinusitis. We were able to collect clinical data for 11 of the 12 with 1 case being lost follow-up. This patient had imaging in our institution but decided to leave the hospital without treatment. Since this patient had two complications (optic nerve ischemia and meningitis which were detected on imaging), we decided to include this patient in our study despite the fact that there is no data about treatment and microbiology. In 4 cases, the SOVT was attributed to trauma. In 3 cases SOVT were noted incidentally and without significant orbital symptoms.

4.1. Complications

In three cases (12%), we detected paralysis of cranial nerves, all of which had the simultaneous CST. In two patients (8%) the SOVT was complicated by septic thrombosis of internal jugular veins (Lemierre’s syndrome) both had CST as well. The Lemierre’s syndrome has never been reported as a complication of SOVT before. The SOVT was complicated by acute cerebral hemispheric infarction and death in one patient, which was because of mucormycosis infection and reveals the mortality rate of SOVT to be 4% in the presented cohort. Optic nerve infarction was seen in one case (4%) diagnosed by imaging. In three cases, the SOVT was complicated by intracranial infection (subdural empyema, ventriculitis and temporal lobe abscess) revealing 16% chance of intracranial involvement (including the mucormycosis patient).

Orbital cellulitis is the most prevalent underlying etiology for SOVT and was detected in 50% of our patients. The orbital cellulitis is more common in the pediatric population [19]. The infectious etiologies are commonly bacterial or polymicrobial, often including aerobic and anaerobic bacteria, less commonly fungal or mycobacteria. The most common bacteria causing orbital cellulitis are Staphylococcus aureus and Streptococci family. The non-spore-forming anaerobes Aeromonas hydrophila, Pseudomonas aeruginosa, and Eikenella corrodens are rare. Mucormycosis and Aspergillus are rare causes of the orbital cellulitis [20].

Most cases of paranasal sinusitis are due to viral infections with few secondary bacterial infections [21]. The Rhinoviruses, influenza/parainfluenza viruses are the most common causes of paranasal sinusitis. The most common bacterial causes of acute purulent sinusitis are Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes. In chronic paranasal sinusitis, the most common isolated bacteria are staphylococcus aureus and anaerobic bacteria (Prevotella and Porphyromonas, Fusobacterium and Peptostreptococcus spp). Pseudomonas aeruginosa and other aerobic and facultative gram-negative rods can be seen in immunocompromised patients. Fungi and Pseudomonas aeruginosa are common pathogens in neutropenic patients [22].

In our study, 12 patients had septic SOVT, among them the bacteriologic data of 10 cases are available. In 4, the infection was polymicrobial. The most common pathogens in our study were: Staphylococcus aureus (methicillin sensitive and resistant), B-hemolytic Streptococcus, Pseudomonas aeruginosa, Coagulase-negative Staphylococci, Staphylococcus Epidermis, Staphylococcus Intermedius, Mucormycosis, Streptococcus viridans, and Streptococcus constellatus. In our cohort the microbiology of the septic SOVT was different than the acute sinusitis or even orbital cellulitis and has overlap with common bacteria causing chronic sinusitis.

4.2. Treatment

Treatment of the SOVT depends on the underlying etiology and includes anticoagulation, antibiotics and surgery. In our study, the patients with post-traumatic, incidental and aseptic SOVTs were treated by anticoagulation without antibiotics. Treatment response in these groups were appropriate and no complication was noted. All of the septic SOVTs cases were treated with antibiotics. The septic SOVTs with orbital abscess required surgical drainage. From 12 cases of septic SOVT data, 11 cases were available; all of which received antibiotics, and 9 cases underwent sinus and orbital surgery.

4.3. Limitations

Our study is limited because it is retrospective. One patient was lost to follow-up, and microbiologic results of all septic SOVT were not available. In addition, we tried to follow the patients regarding the final visual accuracy and any permanent visual defect after treatment of SOVT, but the ophthalmologic data was not available in all patients. Despite the above-mentioned limitations, based on our knowledge, our study includes the largest published patient population of the SOVT to date.

5. Conclusion

The SOVT is a rare condition with many underlying etiologies. Its symptoms overlap with the orbital cellulitis, and post-contrast CT and MRI is critical for diagnosis. The treatment and prognosis of the SOVT depend on the underlying etiology. Based on underlying etiology, SOVT can be classified into different categories including:

  • A.)

    Incidental SOVT (good prognosis, usually self-limited and treated by anticoagulation)

  • B.)

    Post-traumatic and post-surgical SOVT (usually good prognosis which is treated by anticoagulation)

  • C.)

    Septic SOVT (secondary to paranasal sinusitis, orbital cellulitis or a history of paranasal sinus surgery with aggressive behavior, different organisms in comparison to the usual cause of acute sinusitis with a high risk of complication which requires specific antibiotics, anticoagulation and surgery)

  • D.)

    Aseptic SOVT (secondary to inflammatory-autoimmune diseases, coagulopathy, CCF and direct tumor invasion, usually requiring treatment for the underlying condition in association with anticoagulation).

  • E.)

    The CT and MR imaging studies are vital to the correct diagnosis and management of patients with SOVT. Evidence of sinusitis or a history of functional sinus surgery is critical to the diagnosis of septic SOVT. The antibiotic therapy of the septic SOVT must cover the Staphylococcus (including the Methicillin-Resistant Staphylococcus aureus), Pseudomonas, Streptococcus, and mucormycosis families.

Funding

None.

Author contributions

HS, OS, and NA contributed conception and design of the study; HS organized the database; HS, OS, NA, and ES wrote the first draft of the manuscript; MV wrote sections of the manuscript. All authors contributed to manuscript revision, read and approved the submitted version.

Acknowledgements

This work was supported in part by an unrestricted grant from the Research to Prevent Blindness, Inc. New York, N.Y.

Contributor Information

Houman Sotoudeh, Email: hsotoudeh@uabmc.edu.

Omid Shafaat, Email: omid.shafaat@yahoo.com.

Noha Aboueldahab, Email: naboueldahab@uabmc.edu.

Michael Vaphiades, Email: mvaphiades@uabmc.edu.

Ehsan Sotoudeh, Email: ehsansotoudeh@gmail.com.

Joshua Bernstock, Email: jbernstock@partners.org.

References

  • 1.Park H.S., Gye H.J., Kim J.M., Lee Y.J. A patient with branch retinal vein occlusion accompanied by superior ophthalmic vein thrombosis due to severe superior ophthalmic vein enlargement in a patient with graves ophthalmopathy. J. Craniofac. Surg. 2014;25(4):e322–4. doi: 10.1097/SCS.0000000000000586. [DOI] [PubMed] [Google Scholar]
  • 2.Gupta R.K., Jamjoom A.A., Devkota U.P. Superior sagittal sinus thrombosis presenting as a continuous headache: a case report and review of the literature. Cases J. 2009;2:9361. doi: 10.1186/1757-1626-2-9361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Michaelides M., Aclimandos W. Bilateral superior ophthalmic vein thrombosis in a young woman. Acta Ophthalmol. Scand. 2003;81(1):88–90. doi: 10.1034/j.1600-0420.2003.00028_9.x. [DOI] [PubMed] [Google Scholar]
  • 4.Lim L.H., Scawn R.L., Whipple K.M., Oh S.R., Lucarelli M.J., Korn B.S., Kikkawa D.O. Spontaneous superior ophthalmic vein thrombosis: a rare entity with potentially devastating consequences. Eye (Lond.) 2014;28(3):348–351. doi: 10.1038/eye.2013.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mandic J.J., Mandic K., Mrazovac D. Superior ophthalmic vein thrombosis with complete loss of vision as a complication of autoimmune and infective conditions. Ocul. Immunol. Inflamm. 2018;26(7):1066–1068. doi: 10.1080/09273948.2017.1313433. [DOI] [PubMed] [Google Scholar]
  • 6.Cumurcu T., Demirel S., Keser S., Bulut T., Cavdar M., Dogan M., Sarac K. Superior ophthalmic vein thrombosis developed after orbital cellulitis. Semin. Ophthalmol. 2013;28(2):58–60. doi: 10.3109/08820538.2012.736007. [DOI] [PubMed] [Google Scholar]
  • 7.Bauer J., Kansagra K., Chao K.H., Feng L. Transfemoral thrombectomy in the cavernous sinus and superior ophthalmic vein. J. Neurointerv. Surg. 2018;10(5):e8. doi: 10.1136/neurintsurg-2017-013571.rep. [DOI] [PubMed] [Google Scholar]
  • 8.Kim J., Kang S. Asymmetric superior ophthalmic vein thrombosis due to sepsis induced by a deep neck infection. J. Clin. Exp. Ophthalmol. 2015;6(454) [Google Scholar]
  • 9.van der Poel N.A., de Witt K.D., van den Berg R., de Win M.M., Mourits M.P. Impact of superior ophthalmic vein thrombosis: a case series and literature review. Orbit. 2018:1–7. doi: 10.1080/01676830.2018.1497068. [DOI] [PubMed] [Google Scholar]
  • 10.Rao R., Ali Y., Nagesh C.P., Nair U. Unilateral isolated superior ophthalmic vein thrombosis. Indian J. Ophthalmol. 2018;66(1):155–157. doi: 10.4103/ijo.IJO_791_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mishima M., Yumoto T., Hashimoto H., Yasuhara T., Iida A., Tsukahara K., Sato K., Ugawa T., Otsuka F., Ujike Y. Superior ophthalmic vein thrombosis associated with severe facial trauma: a case report. J. Med. Case Rep. 2015;9:244. doi: 10.1186/s13256-015-0737-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sakamoto M., Kurimoto T., Mori S., Ueda K., Keshi Y., Yamada Y., Azumi A., Shimono T., Nakamura M. Vasculitis with superior ophthalmic vein thrombosis compatible with neuro-neutrophilic disease. Am. J. Ophthalmol. Case Rep. 2018;12:39–44. doi: 10.1016/j.ajoc.2018.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Park J., Armstrong G.W., Cestari D.M. Spontaneous superior ophthalmic vein thrombosis in a transgender man with systemic lupus erythematosus. LGBT Health. 2019;6(4):202–204. doi: 10.1089/lgbt.2018.0099. [DOI] [PubMed] [Google Scholar]
  • 14.Sambhav K., Shakir O., Chalam K.V. Bilateral isolated concurrent superior ophthalmic vein thrombosis in systemic lupus erythematosus. Int. Med. Case Rep. J. 2015;8:181–183. doi: 10.2147/IMCRJ.S87518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Baidoun F., Issa R., Ali R., Al-Turk B. Acute unilateral blindness from superior ophthalmic vein thrombosis: a rare presentation of nephrotic syndrome from class IV lupus nephritis in the absence of antiphospholipid or anticardiolipin syndrome. Case Rep. Hematol. 2015;2015 doi: 10.1155/2015/413975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dey M., Charles Bates A., McMillan P. Superior ophthalmic vein thrombosis as an initial manifestation of antiphospholipid syndrome. Orbit. 2013;32(1):42–44. doi: 10.3109/01676830.2012.736600. [DOI] [PubMed] [Google Scholar]
  • 17.Habib N., Lessard K. Superior and inferior ophthalmic vein thrombosis in the setting of lung cancer. Case Rep. Oncol. Med. 2018;2018 doi: 10.1155/2018/6025274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Adam C.R., Shields C.L., Gutman J., Kim H.J., Hayek B., Shore J.W., Braunstein A., Levin F., Winn B.J., Vrcek I., Mancini R., Linden C., Choe C., Gonzalez M., Altschul D., Ortega-Gutierrez S., Paramasivam S., Fifi J.T., Berenstein A., Durairaj V., Shinder R. Dilated superior ophthalmic vein: clinical and radiographic features of 113 cases. Ophthalmic Plast Reconstr Surg. 2018;34(1):68–73. doi: 10.1097/IOP.0000000000000872. [DOI] [PubMed] [Google Scholar]
  • 19.Al-Madani M.V., Khatatbeh A.E., Rawashdeh R.Z., Al-Khtoum N.F., Shawagfeh N.R. The prevalence of orbital complications among children and adults with acute rhinosinusitis. Braz. J. Otorhinolaryngol. 2013;79(6):716–719. doi: 10.5935/1808-8694.20130131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Danishyar A., Sergent S.R. StatPearls Publishing; Treasure Island (FL): 2019. Orbital Cellulitis. [PubMed] [Google Scholar]
  • 21.Worrall G. Acute sinusitis. Can. Fam. Physician. 2008;54(January 1):82–83. [PMC free article] [PubMed] [Google Scholar]
  • 22.Brook I. Microbiology of sinusitis. Proc. Am. Thorac. Soc. 2011;8(1):90–100. doi: 10.1513/pats.201006-038RN. [DOI] [PubMed] [Google Scholar]

Articles from European Journal of Radiology Open are provided here courtesy of Elsevier

RESOURCES